ATHE - alteritytherapeutics.com Profit before interest, taxes and amortization
Patient safety in Alterity Therapeutics (ATHE) studies relies on strict temperature control during drug transportation. At the same time, Alterity Therapeutics is heavily dependent on external laboratories, which complicates the process of switching contractors. A scientific staff of PhD specialists maintains an academic approach to Parkinson's therapy. The operating profit dynamics clearly demonstrate the financial condition, where the indicator value reaches 0.00.
Alterity Therapeutics Limited - analytical breakdowns and key metrics (ATHE)
- current price and projected stock value:
- market capitalization statistics:
- book capitalization data:
- debt level and financial liquidity data:
Aggregate Debt to Capital Alterity Therapeutics|ATHE - Long-Term Debt to Equity Ratio|Current Liabilities to Capital Alterity Therapeutics Ltd.|ATHE - Company Total Debt|Debt to Net Assets Ratio Alterity Therapeutics|ATHE - Company Long-Term Liabilities|Amount of Current Liabilities Alterity Therapeutics|Intermediate Coverage Ratio alteritytherapeutics.com
- earnings and market ratios statistics:
ATHE - Net Profit|Expected Net Profit Alterity Therapeutics|ATHE - Price to Earnings Ratio|Future Price to Earnings Multiple Alterity Therapeutics Ltd.|ATHE - PEG Multiple|EV/EBITDA Multiple Alterity Therapeutics|ATHE - Profit before payment of interest, taxes and amortization|Earnings per one share for the last 12 months Alterity Therapeutics|ATHE - Net earnings per share (EPS TTM)|Earnings per share growth in annualized terms for the last twelve months alteritytherapeutics.com|ATHE - Net earnings per share growth this year|Earnings growth forecast for next year Alterity Therapeutics
Fundamental company valuation:Alterity Therapeutics
This indicator captures the daily operating cash flow before accounting for tax liabilities and debt service costs, determining the business's fundamental ability to generate cash. Analyzing operating profit in cash terms allows for an assessment of how the scientific authority of Alterity Therapeutics (ATHE) in Parkinson's disease therapy converts into financial stability, minimizing risks amid tight monetary policy.
Competitor analysis for Alterity Therapeutics
Company profit before taxes, interest and amortization BIIB (Biogen Idec)|Neurocrine Biosciences - Operating profit EBITDA|Profit before interest, taxes and amortization regencellbioscience.com|Axsome Therapeutics, Inc. (AXSM) - Profit before payment of interest, taxes and amortization|ACADIA Pharma - Income before deduction of interest, taxes and amortization|XENE (Xenon Pharmaceuticals Inc) - Operating profit EBITDA|Viking Therapeutics Corp (VKTX) - Operating income before deduction of amortization|Operating profit before deduction of amortization SUPN (Supernus Pharmaceuticals)|Company profit before taxes, interest and amortization CPRX|Denali Therapeutics Inc. - Operating profit before deduction of amortization|Harmony Biosciences Inc (HRMY) - Profit before interest, taxes and amortization|BHVN: Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization AMLX (Amylyx Corp)|TRVI (Trevi Therapeutics) - Operating profit before deduction of amortization|PRAX: Company profit before taxes, interest and amortization|AVXL (Anavex Life Sciences Corp.) - Operating profit EBITDA|CBLL: Income before deduction of interest, taxes and amortization|Operating profit EBITDA PRTA|ALEC - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization Annexon, Inc. ANNX|Income before deduction of interest, taxes and amortization OMER|Neurogene - Operating profit EBITDA|ACIU - Operating profit EBITDA|Voyager Pharma (VYGR) - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization NMRA (Neumora Corp)|SCLX (Scilex Holding Company) - Operating profit EBITDA|Profit before interest, taxes and amortization tevogen.com TVGN|Operating profit before deduction of amortization ACOG (Alpha Cognition)|Operating profit EBITDA Cognition Therapeutics Inc. (CGTX)|Inhibikase - Operating profit before deduction of amortization|Company profit before taxes, interest and amortization SAVA (Cassava Pharma)|Assertio Therapeutics - Operating profit EBITDA|Operating income before deduction of amortization Coya Therapeutics, Inc. COYA|VTGN: Operating profit EBITDA|Operating profit before deduction of amortization Ovid Therapeutics|Profit before payment of interest, taxes and amortization Acumen Pharma|CervoMed Corporation (CRVO) - Operating income before deduction of amortization|Operating profit EBITDA CLNN|Operating profit EBITDA pepgen.com (PEPG)|Jupiter Neurosciences - Operating profit before deduction of amortization|Company profit before taxes, interest and amortization RLMD (Relmada Therapeutics Inc)|Annovis Bio Corp - Operating profit EBITDA|Income before deduction of interest, taxes and amortization GRCE (Grace Therapeutics, Inc.)|AIFF: Operating profit EBITDA|Profit before interest, taxes and amortization Klotho Neurosciences (KLTO)|Profit before payment of interest, taxes and amortization NeuroSense Therapeutics Ltd|Operating profit before amortization RVPH (Reviva Pharmaceuticals Holdings Inc.)|Operating profit EBITDA MTVA|NRXS - Profit before interest, taxes and amortization|Helius Medical Technologies - Operating profit before deduction of amortization|Operating profit EBITDA Passage Bio Inc. PASG|NEUP - Profit before payment of interest, taxes and amortization|Income before deduction of interest, taxes and amortization NERV (Minerva Neurosciences Inc)|Athira (ATHA) - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization Addex (ADXN)|ALZN (Alzamend Neuro Inc.) - Operating profit EBITDA|Operating profit EBITDA Cyclerion|Profit before payment of interest, taxes and amortization Protagenic Therapeutics (PTIX)|Profit before payment of interest, taxes and amortization KTTA (pasitheaclinics.com)|Cortigent - Operating profit before deduction of amortization|Company profit before taxes, interest and amortization ATXI (Avenue Therapeutics Inc)|Brainstorm Cell - Operating profit EBITDA|Profit before interest, taxes and amortization caratherapeutics.com|Chromocell Therapeutics Corp. (CHRO) - Profit before payment of interest, taxes and amortization|Eliem Therapeutics Inc. - Income before deduction of interest, taxes and amortization|ITCI (Intra-Cellular Therapies Inc.) - Operating profit EBITDA|Longboard (LBPH) - Operating income before deduction of amortization|Operating profit before deduction of amortization MRNS (Marinus Pharmaceuticals)|Company profit before taxes, interest and amortization NKGN|NeuroBo Pharmaceuticals, Inc. - Operating profit before deduction of amortization|Sage Therapeutics Inc. (SAGE) - Profit before interest, taxes and amortization|SNPX: Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization TRVN (Trevena Inc)|VIGL (vigilneuro.com) - Operating profit before deduction of amortization|WENA: Company profit before taxes, interest and amortization|CERE (Cerevel Therapeutics, Inc.) - Operating profit EBITDA
